A pilot double-blind randomised placebo-controlled trial of the effects of fixed-dose combination therapy ('polypill') on cardiovascular risk factors

International Journal of Clinical Practice
F MalekzadehR Malekzadeh

Abstract

Our objective was to investigate the effects and tolerability of fixed-dose combination therapy on blood pressure and LDL in adults without elevated blood pressure or lipid levels. This was a double-blind randomised placebo-controlled trial in residents of Kalaleh, Golestan, Iran. Following an 8-week placebo run-in period, 475 participants, aged 50 to 79 years, without cardiovascular disease, hypertension or hyperlipidaemia were randomised to fixed-dose combination therapy with aspirin 81 mg, enalapril 2.5 mg, atorvastatin 20 mg and hydrochlorothiazide 12.5 mg (polypill) or placebo for a period of 12 months. The primary outcomes were changes in LDL-cholesterol, systolic and diastolic blood pressure and adverse reactions. Analysis was by intention-to-treat basis. At baseline, there were differences in systolic blood pressure (6 mmHg). Taking account of baseline differences, at 12 months, polypill was associated with statistically significant reductions in blood pressure (4.5/1.6 mmHg) and LDL-cholesterol (0.46 mmol/l). The study drug was well tolerated, but resulted in the modest reductions in blood pressure and lipid levels. The effects of the polypill on blood pressure and lipid levels were less than anticipated, raising quest...Continue Reading

References

Jul 20, 1989·The New England Journal of Medicine·UNKNOWN Steering Committee of the Physicians' Health Study Research Group
Jan 30, 1988·British Medical Journal·R PetoS Norton
Jun 29, 2002·BMJ : British Medical Journal·M R Law, N J Wald
Mar 27, 2003·Journal of Hypertension·C M M LawesUNKNOWN Asia Pacific Cohort Studies Collaboration
Jun 28, 2003·BMJ : British Medical Journal·N J Wald, M R Law
Aug 18, 2004·Public Health·M Asadi-LariD Gray
Sep 8, 2004·Expert Review of Cardiovascular Therapy·William H Frishman, Andrea L Zuckerman
Dec 15, 2004·British Journal of Cancer·A PourshamsR Malekzadeh
Mar 9, 2005·The New England Journal of Medicine·Paul M RidkerJulie E Buring
Oct 19, 2005·Annals of Internal Medicine·UNKNOWN Combination Pharmacotherapy and Public Health Research Working Group
Jan 19, 2007·The New England Journal of Medicine·K Srinath Reddy
Mar 27, 2007·The Annals of Thoracic Surgery·Andrew J GrahamJoanne Clifton
Sep 5, 2007·Bulletin of the World Health Organization·Ardeshir KhosraviAlan D Lopez
Nov 22, 2007·Sozial- Und Präventivmedizin·Alfredo Morabia, Thomas Abel
Nov 11, 2008·The New England Journal of Medicine·Paul M RidkerUNKNOWN JUPITER Study Group
Nov 11, 2008·JAMA : the Journal of the American Medical Association·Hisao OgawaUNKNOWN Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial Investigators
Dec 24, 2008·Nature Clinical Practice. Cardiovascular Medicine·Denis XavierUNKNOWN Indian Polycap Study (TIPS) Investigators
Dec 24, 2008·Nature Clinical Practice. Cardiovascular Medicine·Antonio Guglietta, Marta Guerrero

❮ Previous
Next ❯

Citations

May 16, 2013·Journal of Hypertension·Masoud M MalekzadehReza Malekzadeh
Jul 27, 2010·International Journal of Clinical Practice·A S Wierzbicki, R Minhas
Feb 22, 2012·International Journal of Clinical Practice·A S WierzbickiA Viljoen
Aug 30, 2012·BMC Public Health·Manisha NairDorairaj Prabhakaran
Jul 21, 2012·PloS One·David S WaldNicholas J Wald
Mar 29, 2014·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Oda Kristine SandliLars Slørdal
Mar 29, 2014·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Oda Kristine SandliLars Slørdal
Sep 13, 2013·Journal of Cardiovascular Disease Research·Jaykaran CharanDeepak Saxena
Jul 6, 2014·The American Journal of Cardiology·Steven G Chrysant, George S Chrysant
Jan 12, 2011·Annual Review of Public Health·Kaustubh C DabhadkarK M Venkat Narayan
Nov 13, 2015·Expert Opinion on Drug Delivery·Ruth Webster, Anthony Rodgers
Jan 20, 2016·Current Hypertension Reports·Steven G Chrysant, George S Chrysant
Jan 10, 2016·International Journal of Cardiology·José M CastellanoValentín Fuster
Aug 3, 2011·Seminars in Thoracic and Cardiovascular Surgery·Ginés Sanz, Valentin Fuster
Dec 15, 2015·Future Cardiology·Vivencio Barrios, Carlos Escobar
Aug 10, 2013·Annals of Neurology·Aaron W Grossman, Joseph P Broderick
Dec 15, 2012·The Mount Sinai Journal of Medicine, New York·Ginés Sanz, Valentin Fuster
Aug 12, 2014·Journal of the American College of Cardiology·José M CastellanoValentin Fuster
Nov 13, 2012·Expert Opinion on Pharmacotherapy·Antonia Delgado-Montero, Jose L Zamorano
Apr 22, 2015·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Massimo VolpeAllegra Battistoni
Dec 7, 2010·Preventive Medicine·David S Wald, Nicholas J Wald
Jun 3, 2016·Expert Opinion on Pharmacotherapy·Jaideep PatelMaciej Banach
Jun 29, 2016·International Journal of Public Health·Abdullah GandomkarReza Malekzadeh
Oct 21, 2016·Expert Opinion on Investigational Drugs·Dhaval KolteMaciej Banach
Oct 21, 2016·The Journal of Clinical Hypertension·Mihály B TapolyaiTibor Fülöp
Apr 20, 2012·European Journal of Preventive Cardiology·Torben JørgensenUNKNOWN PEP section of EACPR
Oct 25, 2011·European Journal of Preventive Cardiology·Melvin LafeberUNKNOWN SPACE collaboration
Apr 23, 2014·Annals of Global Health·Brandon Wiley, Valentin Fuster
Feb 8, 2013·Therapeutic Advances in Cardiovascular Disease·Richard Kones
Nov 18, 2017·American Journal of Epidemiology·Hossein PoustchiReza Malekzadeh
Mar 7, 2017·The Cochrane Database of Systematic Reviews·Ehete BahiruMark D Huffman
Feb 21, 2018·International Journal of Stroke : Official Journal of the International Stroke Society·Michael BraininAnita Wiseman
May 25, 2011·Circulation·Barry A Franklin, Mary Cushman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.